{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T13:52:46Z","timestamp":1753883566370,"version":"3.41.2"},"reference-count":9,"publisher":"The Endocrine Society","issue":"3","license":[{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,9]]},"DOI":"10.1210\/endocr\/bqad003","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T20:05:33Z","timestamp":1673640333000},"source":"Crossref","is-referenced-by-count":2,"title":["Targeting of a New Node in Lipid Metabolism as a Potential Treatment Strategy for ACC"],"prefix":"10.1210","volume":"164","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3946-1835","authenticated-orcid":false,"given":"Christopher R","family":"LaPensee","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes, University of Michigan , Ann Arbor, MI 48106 , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary D","family":"Hammer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes, University of Michigan , Ann Arbor, MI 48106 , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2023,1,13]]},"reference":[{"key":"2023012711065242600_bqad003-B1","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/er.2013-1029","article-title":"Adrenocortical carcinoma","volume":"35","author":"Else","year":"2014","journal-title":"Endocr Rev"},{"key":"2023012711065242600_bqad003-B2","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1210\/en.2015-1367","article-title":"Mitotane inhibits sterol-O-acyl transferase 1 triggering lipid-mediated endoplasmic Reticulum stress and apoptosis in adrenocortical carcinoma cells","volume":"156","author":"Sbiera","year":"2015","journal-title":"Endocrinology"},{"key":"2023012711065242600_bqad003-B3","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1210\/en.2015-2052","article-title":"ATR-101, a selective and potent inhibitor of acyl-CoA acyltransferase 1, induces apoptosis in H295R adrenocortical cells and in the adrenal Cortex of dogs","volume":"157","author":"LaPensee","year":"2016","journal-title":"Endocrinology"},{"issue":"5","key":"2023012711065242600_bqad003-B4","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s10637-020-00899-1","article-title":"A phase 1 study of nevanimibe HCl, a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, in adrenocortical carcinoma","volume":"38","author":"Smith","year":"2020","journal-title":"Invest New Drugs"},{"issue":"9","key":"2023012711065242600_bqad003-B5","doi-asserted-by":"crossref","first-page":"bqac102","DOI":"10.1210\/endocr\/bqac102","article-title":"Mitotane targets lipid droplets to induce lipolysis in adrenocortical carcinoma","volume":"163","author":"Warde","year":"2022","journal-title":"Endocrinology"},{"key":"2023012711065242600_bqad003-B6","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1530\/ERC-20-0031","article-title":"Liver X receptor inhibition potentiates mitotane-induced adrenotoxicity in ACC","volume":"27","author":"Warde","year":"2020","journal-title":"Endocr Relat Cancer"},{"key":"2023012711065242600_bqad003-B7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.addr.2020.07.013","article-title":"Lipids and cancer: emerging roles in pathogenesis, diagnosis and therapeutic intervention","volume":"159","author":"Butler","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"issue":"8","key":"2023012711065242600_bqad003-B8","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1210\/JC.2015-2080","article-title":"Lipoprotein-free mitotane exerts high cytotoxic activity in adrenocortical carcinoma","volume":"100","author":"Hescot","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2023012711065242600_bqad003-B9","first-page":"2149","article-title":"Potentiation of mitotane action by rosuvastatin: new insights for adrenocortical carcinoma management","volume":"54","author":"Boulate","year":"2019","journal-title":"Int J Oncol"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/endo\/advance-article-pdf\/doi\/10.1210\/endocr\/bqad003\/48687488\/bqad003.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/164\/3\/bqad003\/48911111\/bqad003.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/164\/3\/bqad003\/48911111\/bqad003.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T11:08:20Z","timestamp":1674817700000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/doi\/10.1210\/endocr\/bqad003\/6986713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,9]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,1,9]]}},"URL":"https:\/\/doi.org\/10.1210\/endocr\/bqad003","relation":{},"ISSN":["1945-7170"],"issn-type":[{"type":"electronic","value":"1945-7170"}],"subject":[],"published-other":{"date-parts":[[2023,3,1]]},"published":{"date-parts":[[2023,1,9]]},"article-number":"bqad003"}}